Basal insulin or premix analogue therapy in type 2 diabetes patients.

@article{Raskin2007BasalIO,
  title={Basal insulin or premix analogue therapy in type 2 diabetes patients.},
  author={Philip R Raskin and Priscilla A. Hollander and Andrew W. Lewin and Robert A. Gabbay and Bruce W Bode and Alan J. Garber},
  journal={European journal of internal medicine},
  year={2007},
  volume={18 1},
  pages={56-62}
}
BACKGROUND We sought to compare the safety and efficacy of biphasic insulin aspart 30 (BIAsp 30) given twice daily with once-daily insulin glargine in patients with type 2 diabetes beginning insulin therapy and who did not use thiazolidinediones, which are contraindicated with insulin in the European Union, in a subpopulation (N=157) of the INITIATE study. METHODS At baseline, HbA(1c) was >/=8.0% on >/=1000 mg/day metformin alone or in combination with other oral antidiabetic drugs (OADs; e.g… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 27 extracted citations

Similar Papers

Loading similar papers…